Qorvo® to Present at Goldman Sachs Technology and Internet Conference
Feb 02, 2016 13:00 pm UTC| Business
GREENSBORO, N.C. and HILLSBORO, Ore., Feb. 02, 2016 -- Qorvo® (Nasdaq:QRVO), a leading provider of core technologies and RF solutions for mobile, infrastructure and aerospace/defense applications, today announced that...
Inovio Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 02, 2016 13:00 pm UTC| Business
PLYMOUTH MEETING, Pa., Feb. 02, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that management will participate at three upcoming investor conferences in February: BIO CEO Investor ConferenceFebruary...
FXCM Releases Detailed Execution Study
Feb 02, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 02, 2016 -- FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange (FX) trading and related services, today disclosed detailed information into the quality of execution for Forex Capital...
CoLucid Pharmaceuticals to Present Corporate Overview at the BIO CEO & Investor Conference
Feb 02, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 02, 2016 -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) today announced that Thomas Mathers, Chief Executive Officer, will present a corporate overview at the BIO CEO Investor Conference, being...
Proteon Therapeutics to Present at the 2016 BIO CEO & Investor Conference February 8th
Feb 02, 2016 13:00 pm UTC| Business
WALTHAM, Mass., Feb. 02, 2016 -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, announced...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 02, 2016 13:00 pm UTC| Business
WALTHAM, Mass., Feb. 02, 2016 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following...
Oryzon Genomics to Present at the 18th Annual BIO CEO & Investor Conference 2016
Feb 02, 2016 13:00 pm UTC| Business
BARCELONA, Spain and CAMBRIDGE, Mass., Feb. 02, 2016 -- Oryzon Genomics (ISIN Code: ES0167733015), a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative...